临床外科杂志 ›› 2022, Vol. 30 ›› Issue (5): 444-446.doi: 10.3969/j.issn.1005-6483.2022.05.012

• 论著 • 上一篇    下一篇

不同抗血小板策略对高血压合并2型糖尿病病人冠脉搭桥术后桥血管通畅率的影响

  

  1. 116033 大连市中心医院心脏大血管外科
  • 收稿日期:2021-08-09 接受日期:2021-08-09 出版日期:2022-05-20 发布日期:2022-06-20
  • 通讯作者: 庄熙晶,Email:dlmchcsd@126.com

Comparative study on the effect of different antiplatelet strategy on the patency of bypass grafts after CABG in patients with hypertension complicated with diabetes

  1. Department of Cardiovascular Surgery,Dalian Municipal Central Hospital,Liaoning,Dalian 116033,China
  • Received:2021-08-09 Accepted:2021-08-09 Online:2022-05-20 Published:2022-06-20

摘要: [摘要] 目的 比较替格瑞洛/氯吡格雷对高血压合并2型糖尿病病人冠脉搭桥术后1年桥血管的影响。方法 2016年3月~2020年8月我院行冠脉搭桥术病人78例,随机分为两组,A组41例,采用氯吡格雷治疗,B组37例,采用替格瑞洛治疗。术后1年行CTA检查评估桥血管情况,并随访不良事件。结果 两组一般资料、总桥血管及动脉桥血管通畅率、心绞痛、出血事件比较,差异无统计学意义(P>0.05)。B组静脉桥血管通畅率显著高于A组(89.2% vs.76.8%,P=0.042)。Logistic回归分析显示,替格瑞洛可降低桥血管狭窄风险(OR=2.488,95%CI:1.016~6.091,P=0.046)。结论 冠脉搭桥术后1年,替格瑞洛可更好地维持高血压病合并2型糖尿病病人桥血管通畅。

关键词: 冠脉搭桥术, 高血压病, 2型糖尿病, 替格瑞洛, 氯吡格雷

Abstract: [Abstract] Objective To compare effects of ticagrelor/clopidogrel on bypass in patients with hypertension complicated with diabetes 1 year after CABG.Methods 78 patients undergoing CABG in our hospital from March 2016 to August 2020 were selected and divided into group A(clopidogrel) and group B(ticagrelor).CTA was performed 1 year after the operation to assess bypass,and adverse events were followed up.Results There were no significant differences in general data,total/arterial bridge vessel patency,angina and bleeding events between 2 groups(P>0.05).The patency of vein bypass in group B was significantly higher than group A(76.8%vs.89.2%,P=0.042).Logistic regression suggested that ticagrelor reduced the risk of bridging stenosis(OR=2.488,95%CI:1.016-6.091,P=0.046).〖WTHZ〗Conclusion 1 year after CABG,ticagrelor better maintained bridge patency in hypertensive patients with type 2 diabetes.

Key words: coronary artery bypass grafting, hypertension, type 2 diabetes mellitus, ticagrelor, clopidogrel

[1] 陈国骥 杨华 王存川. 减重手术在代谢外科中的应用及疗效[J]. 临床外科杂志, 2021, 29(9): 801-804.
[2] 郭婕 陈文辉 董世梁 董志勇 王存川. 减重手术在2型糖尿病中的应用[J]. 临床外科杂志, 2021, 29(9): 892-897.
[3] 彭博成, 李宗焕, 漆白文. 术前糖化血红蛋白水平对合并2型糖尿病的老年髋部骨折病人预后的影响[J]. 临床外科杂志, 2021, 29(2): 165-168.
[4] 张光辉, 王存川. 中国肥胖及2型糖尿病外科治疗指南(2019版)解读[J]. 临床外科杂志, 2020, 28(1): 46-48.
[5] 李兴菲 孙世波 孙岩. 减重手术治疗2型糖尿病的进展[J]. 临床外科杂志, 2012, 20(9): 671-673.
[6] 王立军 唐蔚 朱珊 万金男 魏文 孙圣荣. 乳腺癌合并2型糖尿病患者的临床特征分析[J]. 临床外科杂志, 2012, 20(4): 252-252.
[7] 喻敏;王烈;王瑜. Roux-en-Y胃旁路术治疗2型糖尿病的研究进展[J]. 临床外科杂志, 2012, 20(12): 898-900.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[2] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[3] 杨钦;张再重;王烈. 空肠间置术在Siewert Ⅱ型食管胃结合部腺癌中的应用[J]. 临床外科杂志, 2016, 24(11): 816 .
[4] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[5] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[6] 林伟箭;洪雪辉;许淑镇;等. 吸引器在腹腔镜胃癌根治术中的应用体会[J]. 临床外科杂志, 2016, 24(11): 824 .
[7] 吴川清;刘炜圳;帅晓明;等. 超声内镜在胃癌术前诊断中的应用分析[J]. 临床外科杂志, 2016, 24(11): 828 .
[8] 方军;余阳;许涛;等. 小野寺营养预后指数在胃癌患者预后评估中的价值[J]. 临床外科杂志, 2016, 24(11): 831 .
[9] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[10] 吴超;谢迪;汪全新;等. 胃癌肝转移的临床病理特征及危险因素分析[J]. 临床外科杂志, 2016, 24(11): 839 .